Nuclear Medicine Gives Some Patients Hope in Fight Against Cancer, Other Diseases
That treatment for neuroendocrine tumors uses liquid radioactive drugs to specifically target a protein on the cancer cells, obliterating them, without hurting the surrounding, healthy tissue.
It was experimental at the time, but in 2018 the FDA approved it for use in the U.S.
https://www.nbcwashington.com/news/health/nuclear-medicine-gives-some-patients-hope-in-fight-against-cancer-other-diseases/2981717/